Zymeworks Inc. today announced that it has entered into a licensing and collaboration agreement with ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company, to develop an undisclosed number of novel bi-specific antibody ...
Eli Lilly and Company has received priority review status from the US Food and Drug Administration (FDA) for its ramucirumab (IMC-1121B) as a single-agent treatment for advanced gastric cancer following disease progression after initial ...
Tags: Cancer Drug, FDA Priority
Media reports said that two scientists from Eli Lilly and Company are accused for leaking business secrets worth USD 55 million to Jiangsu Hengrui Medicine Co., Ltd. (SHSE: 600276). The Chinese drug maker clarified that it has been abiding ...
Tags: Hengrui Medicine, Health, Medicine
Adimab and Innovent have collaborated to discover, develop and commercialise an antibody-based therapeutic, using Adimab antibody discovery and optimization platform, against a selected specific target. All initial product development ...
Tags: Adimab, Antibody-Based Therapeutic
Eli Lilly and Company has reported 31% increase in net income to $1.21bn, or $1.11 per diluted share, for the second quarter ended on 30 July 2013, compared to $923.6m, or $0.83, for the same period last year. Increase in net income and ...
The European Medicines Agency (EMA) has accepted Eli Lilly and Company and Boehringer Ingelheim's marketing authorisation application (MAA) for a new insulin glargine product, LY2963016, for review. The application has been filed through ...
Specialized diagnostic kits manufacturer Corgenix has signed an agreement with Eli Lilly and Company, a US-based pharmaceutical company, to develop diagnostic technology in support of a Lilly oncology pipeline program. As per the ...
The study in the Journal of the Science of Food and Agriculture states deploying bacteriophages –types of virus – directly on to food to attack and kill harmful bacteria is becoming more popular. Recent studies “strongly ...
Insulet Corporation and Eli Lilly and Company have entered into a collaboration under which Insulet will develop a new version of the OmniPod insulin pump designed to deliver Humulin R U-500 insulin. R U-500 insulin is a regular U-500 ...
Tags: Insulet, Eli Lilly, Insulin Pump
Eli Lilly and Company has acquired two investigational positron emission tomography (PET) tracers from Siemens Medical Solutions USA. PET tracers are aimed to image tau (or neurofibrillary) tangles in the brain, one of two known hallmarks ...
Tags: Eli Lilly, Alzheimer's Research
Boehringer Ingelheim and Eli Lilly and Company have announced the submission of new drug application (NDA) to FDA for an investigational type 2 diabetes mellitus (T2D) treatment, empagliflozin. Empagliflozin belongs to sodium glucose ...
Tags: diabetes therapy, drug application, drug
Denmark-based cancer diagnostics solutions manufacturer Dako announced that it has entered into collaboration agreement with Pfizer in the field of companion diagnostics. The agreement includes a legal framework for various collaboration ...
Tags: cancer diagnostics solutions, Dako, Pfizer
Eli Lilly and Company has reported a net income of $827.2m, or $0.74 per diluted share, for the fourth quarter ended 31 December 2012 compared to $858.2m, or $0.77 per diluted share, for the fourth quarter ended 31 December 2011. Total ...
Tags: Eli Lilly, net income, share
Eli Lilly and Company and Avid Radiopharmaceuticals have announced the approval of Amyvid (Florbetapir (18F)) solution for injection in European Union to detect the beta-amyloid neuritic plaque density in patients with cognitive impairment ...
Tags: diagnostic radiopharmaceutical, Eli Lilly Amyvid, disease
Eli Lilly and Company has reassumed the worldwide development and commercialization rights for novel basal insulin analog giving a scope to diabetes alliance signed with Boehringer concerning LY2605541. Lilly also considers initiating ...
Tags: Eli Lilly, commercialization rights, Boehringer, company news